Diagnos (TSE:ADK) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
DIAGNOS Inc., a Canadian AI-driven healthcare technology company, announced the successful re-election of its board directors and the re-appointment of its auditor following its recent shareholders meeting. Additionally, the company gained shareholder approval for an increase in the stock option plan by 2,000,000 shares, subject to TSX Venture acceptance.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.